title: Multiple drug-intolerant hypertension: a case series utilising a novel-treatment algorithm.
authors.affiliation: Barts BP Centre of Excellence, Barts Heart Centre, St Bartholomew's Hospital, London; William Harvey Research Institute, Queen Mary University of London, London.
authors.forename: Manish
authors.initials: M
authors.lastname: Saxena
authors.affiliation: Barts BP Centre of Excellence; Department of Pharmacy, Barts Heart Centre, St Bartholomew's Hospital, London.
authors.forename: Sotiris
authors.initials: S
authors.lastname: Antoniou
authors.affiliation: Barts BP Centre of Excellence; Department of Pharmacy, Barts Heart Centre, St Bartholomew's Hospital, London.
authors.forename: Nadya
authors.initials: N
authors.lastname: Hamedi
authors.affiliation: Barts BP Centre of Excellence, Barts Heart Centre, St Bartholomew's Hospital, London; Merck Sharp & Dohme Corp.
authors.forename: Paul
authors.initials: P
authors.lastname: Robinson
authors.affiliation: Barts BP Centre of Excellence, Barts Heart Centre, St Bartholomew's Hospital, London; William Harvey Research Institute, Queen Mary University of London, London.
authors.forename: Harjit
authors.initials: H
authors.lastname: Singh
authors.affiliation: Barts BP Centre of Excellence, Barts Heart Centre, St Bartholomew's Hospital, London; William Harvey Research Institute, Queen Mary University of London, London.
authors.forename: Omar
authors.initials: O
authors.lastname: Mukhtar
authors.affiliation: Barts BP Centre of Excellence, Barts Heart Centre, St Bartholomew's Hospital, London.
authors.forename: Vikas
authors.initials: V
authors.lastname: Kapil
authors.affiliation: Barts BP Centre of Excellence, Barts Heart Centre, St Bartholomew's Hospital, London; William Harvey Research Institute, Queen Mary University of London, London.
authors.forename: Melvin D
authors.initials: MD
authors.lastname: Lobo
mesh_terms: D000368:Aged; D000465:Algorithms; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002121:Calcium Channel Blockers / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers